Prostate cancer is a type of cancer that occurs when malignant cells form in the prostate gland, which is a walnut-sized ...

Get any of our free email newsletters — news headlines, e-edition, prep sports, obituaries, entertainment and more.

After establishing dosing and safety in Phase I, researchers will evaluate the drug's anti-tumor activity in patients with PSMA-expressing cancers.

Researchers have identified a new set of urine-based biomarkers that can accurately detect both the presence and severity of ...

Jason M. Hafron, MD, discusses IsoPSA, a novel prostate-specific antigen assay for patients with a PSA > 4ng/ml who are ...

Prostate cancer is a leading cause of cancer-related death among men in the United States. Despite this, widespread adoption ...

A simple urine test was found to detect prostate cancer with greater accuracy than the standard PSA (prostate-specific ...

LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for ...

Breakthrough urine test could soon be used to detect one of the most common forms of cancer - Findings may also lead to drug ...

Illuccix’s broad approval is supported by robust clinical data, including the largest Ga-68-based PSMA data set from the VISION trial 6. The approval of Illuccix® in France has the potential to ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...